BNTX BioNTech SE Stock Quote

BNTX [NASD]

Index	-	P/E	-	EPS (ttm)	-0.40	Insider Own	1.18%	Shs Outstand	314.43M	Perf Week	17.01%
Market Cap	30.02B	Forward P/E	8.89	EPS next Y	14.91	Insider Trans	0.00%	Shs Float	214.95M	Perf Month	22.91%
Income	18.10M	PEG	-	EPS next Q	2.86	Inst Own	9.90%	Short Float	2.22%	Perf Quarter	25.75%
Sales	574.50M	P/S	52.25	EPS this Y	107.10%	Inst Trans	-5.75%	Short Ratio	2.65	Perf Half Y	49.43%
Book/sh	5.20	P/B	25.50	EPS next Y	-45.51%	ROA	1.10%	Target Price	125.79	Perf Year	218.52%
Cash/sh	7.09	P/C	18.70	EPS next 5Y	-	ROE	1.80%	52W Range	37.00 - 131.00	Perf YTD	62.66%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	4.90%	52W High	1.22%	Beta	-
Dividend %	-	Quick Ratio	2.60	Sales past 5Y	-	Gross Margin	87.70%	52W Low	258.38%	ATR	5.64
Employees	1941	Current Ratio	2.80	Sales Q/Q	218.00%	Oper. Margin	-17.10%	RSI (14)	72.81	Volatility	4.37% 4.70%
Optionable	Yes	Debt/Eq	0.17	EPS Q/Q	237.30%	Profit Margin	3.20%	Rel Volume	1.86	Prev Close	129.64
Shortable	Yes	LT Debt/Eq	0.17	Earnings	Mar 30 BMO	Payout	-	Avg Volume	1.80M	Price	132.60
Recom	2.20	SMA20	21.93%	SMA50	21.17%	SMA200	43.39%	Volume	3,344,418	Change	2.28%

Dec-01-20

Downgrade

BofA Securities

Buy → Neutral

$123 → $126

Aug-03-20

Resumed

Berenberg

Buy

$98

Jul-21-20

Upgrade

BofA Securities

Neutral → Buy

$71 → $105

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Nov-04-19

Initiated

Berenberg

Buy

$25

Apr-14-21 05:36PM	CDC Panel Talk Ends Without Vote; Pfizer Boost: Virus Update Bloomberg
05:32PM	Johnson & Johnson and AstraZeneca clot issues are not unexpected it would be more unusual to have no vaccine problems MarketWatch
02:11PM	Vaccine transparency is the best course of action: Doctor Yahoo Finance Video
01:43PM	U.S. in unique position to force increased accountability at the WHO: FDD Yahoo Finance Video
01:15PM	Moderna CEO sees likely need for COVID booster for high-risk groups, eyes flu market Yahoo Finance
11:02AM	Moderna is committed to keep chasing new COVID variants: CEO Yahoo Finance Video
09:34AM	Is J&J's COVID-19 Vaccine Setback a Boon for Other Players? Zacks
08:46AM	EU moves up delivery for 50 million BioNTech and Pfizer COVID-19 vaccine doses MarketWatch
08:21AM	UPDATE 1-EU to raise COVID vaccine supplies from Pfizer in Q2 to 250 mln doses Reuters
08:17AM	Which Vaccine Maker Will Win the Fight Against COVID-19? Zacks
05:35AM	Moderna and Novavax added to mix and match COVID-19 vaccine trial MarketWatch
Apr-13-21 02:09PM	Doctor on J&J vaccine pause: CDC is letting the public know they are taking any side effect seriously Yahoo Finance Video +6.68%
11:00AM	Why Novavax and BioNTech Stocks Are Jumping Today Motley Fool
10:51AM	How COVID-19 transformed the biotech industry Yahoo Finance Video
10:45AM	Vaccine expert: The US doesn't need to rely on J&J vaccine Yahoo Finance
10:42AM	Consumer Price Index Rise 0.6% Zacks
10:28AM	CPI +0.6%: Higher, but Not Scary; JNJ Vax on Hold? Zacks
10:06AM	Moderna, BioNTech stocks surge after regulators halt use of J&J vaccine MarketWatch
10:04AM	Pfizer to pursue bringing COVID-19 vaccine to India after import relaxation Reuters
09:28AM	FDA, CDC recommend pause in Johnson & Johnson COVID-19 vaccine Yahoo Finance Video
05:51AM	Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes? Motley Fool
05:35AM	Vaccine Stocks Checkup: Johnson & Johnson COVID-19 Vaccine Paused TheStreet.com
Apr-12-21 02:43PM	South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report Benzinga
01:51PM	Id still trust vaccines to suppress emergence of more variants: Doctor Yahoo Finance Video
09:30AM	BioNTech SE Sponsored ADR (BNTX) Moves 6.7% Higher: Will This Strength Last? Zacks
07:05AM	J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots Zacks
05:35AM	Hong Kong plans to relax some COVID-19 rules for fully vaccinated residents Reuters
Apr-11-21 12:13PM	South African variant may evade protection from Pfizer vaccine, Israeli study says Reuters
12:07PM	UPDATE 1-South African variant may evade protection from Pfizer vaccine, Israeli study says Reuters
Apr-10-21 05:49AM	Europe Sees Vaccine Output Surge; India in Crisis: Virus Update Bloomberg
Apr-09-21 04:20PM	What Can BioNTech Do for an Encore? InvestorPlace +6.68%
02:13PM	European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters Benzinga
01:39PM	Pfizers vaccine EUA expansion request is extremely welcomed: Doctor Yahoo Finance Video
01:22PM	UPDATE 3-Pfizer, BioNTech seek U.S. emergency nod for COVID-19 vaccine in adolescents Reuters
10:56AM	Pfizer Seeks Vaccine Authorization for Children Ages 12 to 15 TheStreet.com
10:25AM	UPDATE 2-EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022 -EU source Reuters
09:55AM	Europe probes possible blood clot link with Johnson & Johnson COVID vaccine Yahoo Finance UK
09:25AM	BioNTech, Pfizer Gain As EU, Australia Seek More Covid Vaccine Doses Investing.com
Apr-08-21 08:00PM	Pfizer and BioNTech seek US vaccine authorisation for adolescents Financial Times
05:00PM	Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus Zacks
03:23PM	Study shows wearables could detect COVID-19 earlier Yahoo Finance Video
01:23PM	COVID-19 vaccinations are extraordinarily safe: Doctor Yahoo Finance Video
06:04AM	Why Didn't Pfizer and BioNTech Stocks Soar After Their COVID Vaccine Achieved 100% Efficacy in Kids? Motley Fool
Apr-07-21 01:26PM	COVID-19 mitigation is the most effective weapon to avoid fourth wave: Doctor Yahoo Finance Video
12:28PM	NIH Starts Study On Allergic Reactions Risk To Pfizer/BioNTech, Moderna COVID-19 Vaccines Benzinga
11:01AM	White House wont support vaccine passports: Psaki Yahoo Finance Video
Apr-06-21 01:29PM	Theres increasing confidence vaccine supply can meet demand: Doctor Yahoo Finance Video
12:00PM	Moderna Rises as Testing Shows COVID Antibodies Last at Least 6 Months TheStreet.com
11:09AM	The next few weeks 'are going to be critical,' Fauci warns Yahoo Finance
06:57AM	Pfizer's CEO Makes a Claim That Might Shock Anyone Holding Moderna or BioNTech Stock Motley Fool
05:52AM	Why Pfizer and BioNTech's COVID Vaccine Could Be Even Better Than Expected Motley Fool
Apr-05-21 02:06PM	Travel boom poses threat to COVID-19 recovery: Doctor Yahoo Finance Video
01:54PM	Pfizer In Talks With Israel For New COVID-19 Vaccine Supply Deal: Reuters Benzinga
11:25AM	Pfizer says working on new COVID-19 vaccine supply deal to Israel Reuters
08:16AM	BioNTech Stock Has Surged on Covid Vaccine. Its Next Big Hit Might Take a While. Barrons.com
05:37AM	Vaccine Stocks Checkup: Johnson & Johnson, Pfizer Update TheStreet.com
02:05AM	Covid-19 Vaccine Update And Outlook Amid New Variants, Hiccups For Some Vaccine Developers Investor's Business Daily Video
Apr-04-21 10:09AM	The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More Benzinga
Apr-03-21 10:48AM	AstraZeneca woes continue as the Netherlands halts vaccine Yahoo Finance UK
03:00AM	Bullish: Analysts Just Made A Huge Upgrade To Their BioNTech SE (NASDAQ:BNTX) Forecasts Simply Wall St.
Apr-02-21 08:00PM	Hong Kong executives choose China Covid vaccine to get mainland visas Financial Times
01:46PM	UPDATE 1-Turkey begins administering Pfizer/BioNTech COVID-19 shots Reuters
08:45AM	Pfizer and BioNTech's Vaccine Performs Well in the Real World Motley Fool
08:05AM	Turkey begins administering Pfizer/BioNTech COVID-19 shots Reuters
07:03AM	Is Pfizer Giving Its Partner BioNTech the Shaft by Developing mRNA Vaccines on Its Own? Motley Fool
06:17AM	UPDATE 1-Bulgaria to receive 'solidarity' vaccines, says PM Reuters
02:48AM	Bulgaria to receive 'solidarity' vaccines, says PM Reuters
Apr-01-21 08:00PM	Where the magic happens inside BioNTechs innovative vaccine plant Financial Times
05:00PM	Pfizer and BioNTech's Coronavirus Vaccine Remains Effective for at Least 6 Months Motley Fool
04:18PM	'The important thing is to have as many Americans vaccinated as possible': Doctor Yahoo Finance Video
04:15PM	BioNTech Stock Hikes As Pfizer-Partnered Covid Vaccine Appears Durable Investor's Business Daily
04:12PM	EU countries agree to share 'solidarity vaccines' with states in need Reuters
01:46PM	Layers of mitigation against the virus remains critical: Doctor Yahoo Finance Video
12:48PM	UPDATE 3-Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant Reuters
10:35AM	Pfizer and BioNTech say their COVID-19 vaccine is safe and highly effective including against South Africa variant MarketWatch
09:42AM	Pfizer, Biotech vaccine shows strong results after 6 months Yahoo Finance Video
08:25AM	Dow, Gibraltar Industries, Pfizer, BioNTech and Micron highlighted as Zacks Bull and Bear of the Day Zacks
07:33AM	Pfizer-BioNTech COVID-19 Shot Safe, Effective Through Six Months After Second Dose Benzinga
07:27AM	UPDATE 1-Pfizer COVID-19 shot 91% effective in updated data, protective against South African variant Reuters
07:07AM	Pfizer/BioNTech vaccine effective after 6 months; Moderna starts variant trial Yahoo Finance
07:02AM	Pfizer, BioNTech say study of COVID-19 patients six months after second vaccine dose proved it is safe and effective MarketWatch
06:50AM	Pfizer (PFE)/BioNTech COVID-19 Vaccine 100% Effective in Teens Zacks
06:45AM	UPDATE 2-Pfizer COVID-19 shot 91% effective in updated data, protective against South African variant Reuters
06:45AM	Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study GlobeNewswire
06:09AM	Pfizer's Decision to Develop mRNA Vaccines on Its Own: Brilliant or Boneheaded? Motley Fool
05:23AM	Pfizer-BioNTech Vaccine Tests Well Against South African Variant TheStreet.com
04:19AM	UPDATE 1-Hong Kong to resume use of BioNTech COVID-19 vaccines on April 5 Reuters
Mar-31-21 08:30PM	BioNTech SE (BNTX) Q4 2020 Earnings Call Transcript Motley Fool
05:50PM	Dow Dips, Other Markets Up for the Day; Micron (MU) Beats Zacks
05:00PM	ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update Zacks
04:18PM	BioNTech Stock Pops Again Covid Jab Proves 100% Effective In Teenagers Investor's Business Daily
04:05PM	Stock market news live updates: S&P 500 reaches record high, traders eye Biden's infrastructure proposal Yahoo Finance
02:48PM	Pfizer and BioNTech's COVID-19 Vaccine Produces 100% Protection in Kids Motley Fool
01:42PM	Pfizer vaccine 100% effective in 12 to 15 year olds: Study Yahoo Finance Video
10:40AM	Global COVID case tally climbs for fifth straight week, highlighting need to ensure vaccine equity MarketWatch
10:37AM	Why BioNTech Stock Is Jumping Again Today Motley Fool
10:29AM	Pfizer's Late-Stage COVID-19 Vaccine Data In Adolescents Reinforces Bull Case, Analyst Says Benzinga
08:41AM	Company News for Mar 31, 2021 Zacks
07:53AM	Pfizers Covid-19 Vaccine Is 100% Effective in Adolescents, Company Says Barrons.com
07:35AM	Pfizer and BioNTech say COVID-19 vaccine was 100% effective in Phase 3 trial in adolescents MarketWatch

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer.It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody, which is in Phase I/IIa clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience